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Abstract 
AIM
To  investigate  the  intestinal  segment-specific  effects  of  diabetes  and  insulin 
replacement on the density of different subpopulations of submucous neurons. 
METHODS
Ten weeks after the onset of type 1 diabetes samples were taken from the duodenum, 
ileum and colon of  streptozotocin-induce diabetic, insulin-treated diabetic and sex- 
and age-matched control rats. Whole-mount preparations of submucous plexus were 
prepared  from  the  different  gut  segments  for  quantitative  fluorescent 
immunohistochemistry.  The  following  double-immunostainings  were  performed: 
neuronal nitric  oxide synthase  (nNOS) and HuC/D, heme oxygenase  (HO)  1 and 
peripherin, as well as HO2 and peripherin. The density of nNOS-, HO1- and HO2-
immunoreactive (IR) neurons was determined as a percentage of the total number of 
submucous neurons.   
RESULTS
The total number of submucous neurons and the proportion of nNOS-, HO1- and 
HO2-IR subpopulations were not affected in the duodenal ganglia of control, diabetic 
and insulin-treated rats. While the total neuronal number did not change in either the 
ileum or the colon, the density of nitrergic neurons exhibited a 2- and 3-fold increase 
in  the  diabetic  ileum  and  colon,  respectively,  which  was  further  enhanced  after 
insulin replacement.  The presence  of  HO1-  and HO2-IR submucous neurons was 
robust in the colon of controls (38.4%-50.8%), whereas it was significantly lower in 
the  small  intestinal  segments  (0.0%-4.2%,  P <  0.0001).  Under  pathophysiological 
conditions the only alteration detected was an increase in the ileum and a decrease in 
the colon of the proportion of HO-IR neurons in insulin-treated diabetic animals.   
CONCLUSION
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Diabetes and immediate insulin replacement induce the most pronounced region-
specific alterations of nNOS-, HO1- and HO2-IR submucous neuronal density in the 
distal parts of the gut. 
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Core tip: Our present findings demonstrate for the first time the segment–specific  
alterations  of  the proportion of  nitrergic,  heme oxygenase  (HO)1-immunoreactive 
(IR) and HO2-IR neurons in the submucous plexus of control, diabetic and insulin-
treated diabetic  rats.  Our results  suggest  that  duodenal  nitrergic  neurons are  not 
affected,  but  ileal  and  colonic  ones  are  induced  to  change  their  neurochemical 
character in diabetes and insulin replacement. The colonic ganglia are abundant in 
HO-IR neurons in both controls and diabetics, whereas insulin treatment decreases 
their proportion. In contrast to the colon, the low amount of HO-IR ileal neurons was 
increased by insulin-treatment.
Bódi  N,  Szalai  Z,  Chandrakumar  L,  Bagyánszki  M.  Region-dependent  effects  of 
diabetes  and  insulin-replacement  on  neuronal  nitric  oxide  synthase-  and heme 
oxygenase-immunoreactive submucous neurons. World J Gastroenterol 2017; In press
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INTRODUCTION
Diabetes has widespread effects on gastrointestinal (GI) function causing different GI 
symptoms, including nausea, vomiting, abdominal pain, constipation or diarrhoea [1]. 
The  functional  impairments  of  the  GI  tract  in  diabetes  are  studied  intensively; 
however,  the  complexity  of  diabetes-related  pathophysiological  consequences 
hinders  the  attainment  of  clear  findings  about  the  underlying  mechanisms  and 
alterations. An increasing body of evidence confirms that the impaired function of 
the enteric nervous system (ENS) is closely related to the GI syndromes of diabetic 
patients[2-4]. The ENS is an autonomous entity structured as two major ganglionated 
plexi,  i.e., the myenteric and the submucosal plexi. The myenteric plexus regulates 
intestinal  motility[5].  It  is  more  difficult  to  determine the functions  of  submucous 
neurons because of differences in the organization and function of the submucous 
plexus:  it  is  more  complex  in  large  mammals  with  at  least  two  distinct  nerve 
networks than in small rodents. Submucous neurons regulate electrolyte absorption 
across the mucosa, blood flow and mucosal secretion in small rodents[6,7], moreover 
in large mammals it is involved both in mucosal and motility processes[8,9]. 
The alterations in the number of inhibitory neurons including nitrergic neurons in 
diabetes and their responsiveness to insulin treatment have been intensively studied, 
but these investigations mainly target the myenteric plexus. Furthermore, a region-
specific susceptibility of the nitrergic neurons to diabetes- as well as insulin-related 
damages was identified in the myenteric plexus[10-12].   
In  contrast  to  the  intense  interest  in  the  neurochemical  characterization  of 
myenteric neurons in non-diabetic and diabetic state, the submucous plexus is poorly 
investigated in diabetes. A decreased total and an unchanged nitrergic submucous 
neuronal  density were found in the jejunum and ileum in streptozotocin-induced 
(STZ) diabetes as compared to the controls[13,14], but we have no information about the 
effects of insulin treatment on the submucous neurons.
Long-lasting hyperglycemia can lead to oxidative stress, an imbalance between the 
increased  production  of  reactive  oxygen  and  nitrogen  species  (RONS)  and  the 
decrease  of  antioxidant  defence  mechanisms,  which  have  been  implicated  in  the 
damage of the ENS such as quantitative and neurochemical changes of the enteric 
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neurons. The systemic oxidative state in type 2 diabetic patients was proved by the 
determination  of  serum  oxidative  stress  markers  including  increased 
malondialdehyde  level  and  superoxide  dismutase  activity,  decreased  glutathione 
reductase,  glutathione  peroxidase,  glucose-6-phosphate  dehydrogenase  enzyme 
activities and glutathione level[15]. This oxidative state was further confirmed by the 
results from diabetic duodenum and colon of human patients or rats, where it led to 
the apoptosis of enteric neurons and to neuronal remodelling in the ENS[16,17].   
The heme catabolizing heme oxygenase (HO) enzyme plays an essential role in 
antioxidant defence mechanisms. This enzyme has two main isoforms including the 
inducible HO1 and the constitutive HO2. Of the two, HO2 is described as the isoform 
widely expressed in the neuronal and non-neuronal cell types of the healthy GI tract,  
and both HO1 and HO2 can be  co-localized with neuronal  nitric  oxide  synthase 
(nNOS)[18-21]. In diabetic rat ileum, the nitrergic myenteric neurons containing HO2 
were more resistant to the effect  of experimentally induced diabetes on cell  body 
size[22].  However,  the  detailed  characterization  of  the  changes  of  HO1-
immunoreactive  (HO1-IR)  and  HO2-IR  submucous  neurons  in  the  different  gut 
regions of diabetic and insulin-treated diabetic rats has not been accomplished.
In view of the interest in understanding the gut segment-dependent changes in the 
submucous  plexus  in  diabetes  and  insulin-treated  diabetes,  our  study  aimed  to 
reveal the region-specific alterations in the density of neurons containing nNOS as 
well  as  HO1 or  HO2 enzymes  in  the  different  segments  of  the  small  and  large 
intestine of control, diabetic and insulin-treated diabetic rats. 
MATERIALS AND METHODS
Animal model
Adult  male Wistar rats  (Crl:WI BR; Toxi-Coop Zrt.)  weighing 210–260 g,  kept on 
standard  laboratory  chow  (Farmer-Mix  Kft.,  Zsámbék)  and  with  free  access  to 
drinking  water  were  used  throughout  the  experiments.  The  rats  were  divided 
randomly into three groups: STZ-induced diabetics (diabetics; n = 6), insulin-treated 
STZ-induced diabetics  (insulin-treated diabetics;  n =  4) and sex- and age-matched 
controls  (n  =  5).  Hyperglycaemia  was  induced  as  described  previously[10,23].  The 
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animals were considered diabetic if the non-fasting blood glucose concentration was 
18  mmol/L.  From  this  time  on,  one  group  of  hyperglycaemic  rats  received  a 
subcutaneous injection of insulin (Humulin M3, Eli Lilly Nederland) each morning 
(2 IU) and afternoon (2 IU).  The blood glucose level and weight of each animal were 
measured weekly. In all procedures involving experimental animals, the principles of 
laboratory  animal  care  (NIH  Publication  No.  85-23,  revised  1985)  were  strictly 
followed, and all  the experiments  were approved in advance by the Local Ethics 
Committee for Animal Research Studies at the University of Szeged.
Tissue handling
Ten weeks after the onset of diabetes, the animals were killed by cervical dislocation 
under chloral  hydrate anaesthesia  (375 mg/kg i.p.).  The gut  segments of  control, 
diabetic and insulin-treated diabetic rats were dissected and rinsed in 0.05  mol/L 
phosphate buffer (PB, pH 7.4). Samples were taken from the duodenum (1 cm distal  
to the pylorus), the ileum (1 cm proximal to the ileocecal junction), and the proximal 
colon  and  processed  for  immunohistochemical  studies.  For  double-labelling 
fluorescent  immunohistochemistry,  the  intestinal  segments  were  cut  along  the 
mesentery, pinched flat and fixed overnight at 4℃ in 4% paraformaldehyde solution 
buffered with 0.1 mol/L PB (pH 7.4). The samples were then washed, and to obtain 
the whole-mounts of the submucous plexus, the muscular layers of the gut wall were 
removed, and the mucosa was extracted by scrapping with a small spatula under an 
Olympus SD30 stereomicroscope. 
Double-labelling fluorescent immunohistochemistry
For  quantitative  immunohistochemistry,  whole-mount  preparations  derived  from 
different gut segments were double-immunostained with nNOS and HuC/D, HO1 
and  peripherin,  as  well  as  HO2  and  peripherin.  Briefly,  after  blocking  the 
preparations in PB containing 0.1% bovine serum albumin, 10% normal goat serum 
and  0.3%  Triton  X-100,  they  were  incubated  overnight  with  anti-nNOS  (rabbit; 
Cayman Chemical, Ann Arbor, MI, the United States of America; final dilution 1:200) 
in combination with anti-HuC/D (mouse; Molecular Probes, Eugene, OR, the United 
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States of America; final dilution 1:50), anti-HO1 (mouse; Novus Biologicals Europe, 
Abington, United Kingdom; final dilution 1:200) or anti-HO2 (mouse;  Santa Cruz 
Biotechnology, Inc., Dallas, TX, the United States of America; final dilution 1:50) in 
combination with anti-peripherin (rabbit; Millipore, Temecula, CA, the United States 
of America;  final dilution 1:400) primary antibodies.  After washing in PB, whole-
mounts  were  incubated  with  anti-rabbit  Alexa  Fluor  488  (Life  Technologies 
Corporation, Molecular Probes, Inc., Eugene, OR, the United States of America; final 
dilution 1:200) and anti-mouse CyTM3 (Jackson ImmunoResearch Laboratories, Inc., 
Baltimore Pike,  PA,  the United States  of  America;  final  dilution 1:200)  secondary 
antibodies for 4 h. All incubations were carried out at room temperature. Negative 
controls  were  performed  by  omitting  the  primary  antibody,  when  no 
immunoreactivity  was  observed.  Whole-mounts  were  mounted  on  slides  in 
EverBriteTM Mounting Medium (Biotium, Inc.,  Hayward,  CA, the United States of 
America),  observed  and  photographed  with  an  Olympus  BX51  fluorescent 
microscope  equipped  with  an  Olympus  DP70  camera.  One  hundred  submucous 
ganglia were taken from each intestinal segment in each experimental group and we 
counted the nNOS-, HO1- and HO2-IR neurons and the HuC/D- and peripherin-IR 
neurons to yield the total number of submucous neurons. We determined the nNOS-, 
HO1- and HO2-IR neurons as a percentage of the total number of neurons.
Statistical analysis
Statistical analysis was performed with one-way ANOVA and the Newman–Keuls 
test. All analyses were carried out with GraphPad Prism 6.0 (GraphPad Software, La 
Jolla, CA, the United States of America). A probability of P < 0.05 was set as the level 
of significance. All data were expressed as mean ± SE.
RESULTS
Pathophysiological characteristics of diabetes
According  to  the  data  shown  in  Table  1,  STZ  promoted  hyperglycaemia  in  the 
diabetic  rats  (23.31 ± 0.53  mmol/L),  but  the  insulin  treatment  prevented  the 
extremely high blood glucose concentration (9.48 ± 0.14 mmol/L). The weight of the 
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animals significantly increased in all groups during the ten weeks of the experiment,  
but the final body weight of diabetic rats was less elevated compared to the control 
and the insulin-treated diabetic animals. 
Proportion of nNOS-IR neurons
To determine the proportion of nNOS-IR neurons in the total submucous neuronal 
number, nNOS and HuC/D double-labelling fluorescent immunohistochemistry was 
applied, as shown in the representative micrograph (Figure 1). In the total number of 
neurons,  no  changes  were  found  between  the  different  gut  segments  within  the 
control  group or  among the  three  experimental  groups  in  the  duodenal,  ileal  or 
colonic intestinal regions (data are not shown). The proportion of nitrergic neurons in 
the  total  neuronal  number  did  not  show  any  differences  between  the  three 
investigated  gut  segments  of  controls  (Figure  2A).  STZ treatment  resulted  in  an 
increase in the proportion of nitrergic neurons in the distal intestinal segments (in the 
ileum  and  colon)  but  not  in  the  duodenum.  The  proportion  of  the  nitrergic 
subpopulation  exhibited  a  2-fold  increase  in  the  ileum  (12%  vs 6%  in  controls), 
whereas  a  3-fold  increase  was  observed  in  the  colon  of  diabetics  (22%  vs 8% in 
controls;  Figure  2B).   The  insulin  treatment  had  no  effect  on  the  proportion  of 
duodenal and colonic nitrergic submucous neurons which, however, was found to 
increase significantly in the ileal segment as compared to the diabetic rats. 
Proportion of HO1-IR neurons
To  visualize  and  quantify  the  occurrence  of  HO1-IR  submucous  neurons,  HO1 
immunohistochemistry was used combined with peripherin as pan-neuronal marker 
(Figure 3).
The distribution of  HO1-IR submucous neurons as  compared to  total  neuronal 
number demonstrated region-dependent differences in the three examined segments 
even  in  the  controls.  The  proportion  of  duodenal  and  ileal  HO1-IR  submucous 
neurons was only 4% and  0%, respectively, but the occurrence of HO1-IR neurons 
was extremely robust in the colon (51%;  P < 0.0001; Figure 4A).  In the diabetics, 
results similar to the controls were obtained along the intestinal tract, with HO1-IR 
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neurons seldom occurring in the small intestine and present  in abundance in the 
large intestine (Figure 4B). In the duodenal segment no change was induced by the 
insulin  treatment  in  the  presence  of  HO1-IR  neurons,  whereas  in  the  ileum 
quantitative analysis of the HO1-IR submucous subpopulation revealed a significant 
increase in the proportion of these neurons in the insulin-treated diabetic group (6%) 
as compared to the control group (0%). In the colonic submucous ganglia we found a 
significant decrease in the insulin-treated diabetics (14%) as compared to the control 
(51%) or the diabetic (38%) groups (Figure 4B).   
Proportion of HO2-IR neurons 
The occurrence of HO2-IR submucous neurons was also calculated as the proportion 
of peripherin-stained total submucous neuronal number (Figure 5). In the controls, 
the  HO2-IR  neurons  demonstrated  a  distribution  similar  to  that  of  the  HO1-IR 
submucous  neurons.  In  the  segments  of  small  intestine,  a  low  level  of  HO2-IR 
neurons was detected (4% in the duodenum, 1% in the ileum), but in the colon this 
proportion was significantly higher (38%;  P < 0.0001; Figure 6A). In the diabetics, 
results  similar  to  the  controls  were  obtained  along  the  intestine;  the  marked 
differences  in  the  ratio  of  HO2-IR  neurons  between  the  different  gut  segments 
remained unchanged (Figure 6B).
Immediate insulin replacement had no effect on the abundance of HO2-IR neurons 
in the duodenum. Although the ileal segment showed the lowest proportion of HO2-
IR neurons compared to the other two control regions, a significant increase in their 
numbers was found in the ileum after insulin replacement (17%) compared to the 
control (1%) and the diabetic rats (6%). The proportion of colonic HO2-IR neurons 
showed a pattern similar to that of the HO1-IR neurons in the same segment. The 
ten-week insulin treatment reduced the proportion of HO2-IR neurons (28%) below 
control level, and this decrease was significant as compared to the diabetic group 
(52%; Figure 6B).
DISCUSSION
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In  the  present  study  we  investigated  the  nitrergic  subpopulation  of  submucous 
neurons similarly to  our earlier  study on the myenteric  plexus.  In  that  study we 
published the gut region-dependent quantitative changes of the total population and 
the  nitrergic  subpopulation  of  myenteric  neurons  in  STZ-induced  diabetic  and 
insulin-treated diabetic  rats[10].  In the present study we demonstrate that the total 
submucous neuronal number is similar in the duodenum, ileum and colon in the 
controls,  and remains unchanged in diabetes as well  as after insulin replacement. 
This  is  in  agreement  with  the  observation  of  Glasiella  et  al[24],  however  their 
investigations are limited to the ileum. Our data reflect that STZ-induced diabetes 
does not induce degenerative changes in the total population of submucous neurons, 
unlike our previous data about the myenteric plexus. Oxidative stress is known to be 
induced  by  hyperglycaemia  in  diabetes  via  the  mitochondrial  overproduction  of 
RONS, which leads to an imbalance between free radical production and antioxidant 
defense molecules or mechanisms[15-17]. We suggest, in accordance with the opinion of 
Lopes et al[13], that submucous neurons may have greater resistance to RONS under 
diabetic conditions.
In  non-diabetic  state,  nitrergic  myenteric  and  submucous  neurons  have  been 
examined along the gut in different rodent species, and it has been described that the 
myenteric  plexus  has  more  nitrergic  neurons  as  compared  to  the  submucous 
plexus[25-27].  Using the same rat model of type 1 diabetes as Izbéki  et al[10],  the gut 
segment-specific  alterations  in  the  two  ganglionated  plexi  can  be  compared. 
According to  the investigation of  the myenteric  plexus in  the controls,  the ileum 
contained the lowest  proportion of  nitrergic  neurons[10],  but  we found no region-
specific differences in the submucous plexus in accordance with other findings [28,29]. 
We  have  revealed  different  effects  of  hyperglycaemia  on  the  ratio  of  nitrergic 
neurons  in  the  two plexi;  a  significant  decrease  was  seen  in  all  segments  of  the 
myenteric plexus, but, with the exception of the duodenum, an increase was found in 
the ileal and colonic submucous ganglia. Our results demonstrate that not only total  
neuronal density but also the nitrergic subpopulation of the two plexi are affected in 
a different way by the diabetic state. 
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Because  of  the  unchanged  total  neuronal  number  in  submucous  ganglia, 
alterations  of  the  neurochemical  character  as  an  adaptation  to  diabetes-related 
oxidative  stress  is  suggested  to  be  in  the  background  of  these  modifications. 
Neurochemical changes as an answer of the ENS to pathological conditions including 
Crohn’s disease, ulcerative colitis or Parkinson’s disease are known[30-32]. Moreover, 
there is evidence that diabetic neuropathy and changes in neurochemical coding can 
occur in the submucous plexus of the ENS[13,14]. We found a similar result in another 
pathological rat model, in chronic ethanol-consumption, where the total myenteric 
neuronal  number  remained  constant,  but  the  density  of  nitrergic  neurons  was 
changed[33,34].  Previous studies  showed that there are few nitrergic  neurons in the 
submucous ganglia, the submucous plexus is more abundant in vasoactive intestinal 
polypeptide (VIP)-IR neurons as compared to the myenteric plexus, and there is a 
high proportion of VIP and nNOS co-localizing neurons in both plexi[14,35]. Zhong et  
al[36] demonstrated that colonic VIP-IR submucous neurons start  to express  nNOS 
during culturing as a  form of functional plasticity.  
Our results reported here show gut segment-specific alterations of not only the 
nitrergic, but also the HO1-IR and HO2-IR submucous neurons, and these alterations 
become  increasingly  pronounced  along  the  proximo-distal  axis  of  the  gut. An 
important  finding  of  this  study  is  that  HO1-IR  and  HO2-IR  neurons  are  more 
abundant in the colon (about half of the colonic neurons was HO-IR) than in the 
small intestinal segments (about 0%-5%) in the controls, and STZ treatment did not 
result in any significant changes in the investigated regions. The question arises as to 
what the reasons underlying these differences are. In non-diabetic state, more RONS 
are generated in the colon then in the small  intestine [37].  It  is  possible  that  under 
worsening oxidative circumstances the pro-oxidant basal state in the colon acts as a 
preconditioning factor inducing the higher physiological activity of both isoforms of 
the antioxidant HO enzymes. This mechanism may play a role in the protection of 
this  segment  against  neuronal  cell  loss  regarding  the  total  submucous  neuronal 
number in diabetic condition, in contrast to earlier findings in the colonic myenteric  
ganglia. The neuroprotective, anti-apoptotic effects of the HO1 enzyme in oxidative 
stress were proved in the central ENS[38,39]. However, we did not investigate the co-
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localization  of  nNOS  with  HO  in  these  neurons,  despite  earlier  findings 
demonstrating  the  beneficial  effects  of  the  coexistence  of  these  enzymes  on  the 
myenteric neurons[22]. Moreover, former studies visualized nNOS-HO2-IR neurons in 
the  submucous  ganglia[19,20,40],  which  suggests  a  protective  role  of  HO,  and  may 
contribute to our  results revealing the increasing proportion of nitrergic neurons in 
the diabetic ileum and colon.     
The  data  about  the  effects  of  insulin  are  contradictory.  While  early  insulin 
replacement was preventive to the total population of colonic myenteric neurons [10], 
we found no changes in the three intestinal regions in the total number of submucous 
neurons of  insulin-treated diabetic  rats.  The density  of  nitrergic  neurons  showed 
similar patterns in the two plexi after insulin replacement,  an increase was found 
from proximal to distal direction, which means significant changes in the ileum and 
the colon as compared to untreated diabetic rats. 
As in the case of the nitrergic subpopulation, not the duodenal, but the ileal and 
colonic HO1- and HO2-IR submucous neurons responded to insulin treatment, but in 
an  opposite  way.  However,  there  were  no  differences  between  the  control  and 
diabetic groups in these two regions and we found an increased density in the ileum, 
but a decreased abundance in the colon of insulin-treated diabetic rats.   
Our results suggest that the three investigated gut segments have different levels of 
responsiveness to immediate insulin replacement in diabetes regarding the nitrergic 
and HO-IR subpopulation of submucous neurons. This is confirmed by our earlier 
findings  in  the  myenteric  neurons  and  in  their  microenvironment  including  the 
capillary  endothelium  adjacent  to  the  myenteric  ganglia[23].  The  environmental 
changes of submucous ganglia were described, such as the alteration of the faeces-
associated  microbiota  in  diabetes  and  insulin-treatment[41]. Moreover, 
microangiopathy as a complication of diabetes in submucosal vessels of the GI tract 
was identified on duodenal  and colon samples from diabetic  patients[42,43].  On the 
other hand, our results are in accordance with the previous contradictory data about 
the  beneficial  or  harmful  effects  of  insulin.  Insulin  was  shown  to  induce  DNA 
damage through the enhanced production of RONS and to increase the risk of cancer 
in  different  cell  types[44,45].  But  insulin  therapy  decreased  vascular  superoxide 
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overproduction  in  diabetic  rats  generated  by  NADPH oxidase,  NOS or  xanthine 
oxidase[46]. It is important to mention that the nitric oxide produced by NOS and the 
carbon  monoxide  generated  by  HO  enzymes  may  have  either  pro-oxidant  or 
antioxidant effects depending on the microenvironment, the duration of production 
and the amount of these gases[47-49].  
This complex background makes it difficult to understand the details of our recent 
findings,  and  further  experiments  are  needed  to  explore  the  mechanisms  of 
physiological  and pathological  events  in  the submucous  neurons in  diabetes  and 
insulin replacement, their relationships and communication with their environment. 
In  summary,  our  present  study  provides  evidence  for  the  first  time  that  the 
neurochemical  character  of  the  nitrergic  submucous  neurons  exhibits  gut  region-
dependent  changes  in  diabetic  and  insulin-treated  diabetic  rats.  In  addition,  we 
prove that HO1-IR and HO2-IR submucous neurons are present in small amounts in 
the small intestine, but in high abundance in the colon of control and diabetic rats, 
and they have segment-specific responsiveness to immediate insulin replacement.   
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Figure 1 Representative fluorescent micrograph of a whole-mount preparation of 
submucous ganglia from the colon of a diabetic rat after nNOS-HuC/D double-
labelling  immunohistochemistry.  Solid  arrows  indicate  neurons  labelled  for 
HuC/D  only,  open  arrows  show  neurons  double-labelled  for  both  nNOS  and 
HuC/D; Scale bar: 50 m.
23
Figure 2 Proportion of nitric oxide synthase-immunoreactive neurons related to the 
total number of submucous neurons in the duodenum, ileum and colon. A: Only in 
controls; B: in control, diabetic and insulin-treated diabetic rats. Data are expressed 
as  mean  ±  SE;  aP  <  0.05  and  eP  <  0.0001  vs controls,  cP  <  0.05  vs diabetics.  IR: 
Immunoreactive; C: Controls; D: Diabetics; ID: Insulin-treated diabetics.
24
Figure 3 Representative fluorescent micrograph of a whole-mount preparation of 
submucous ganglia from the colon of a control rat after HO1-peripherin double-
labelling  immunohistochemistry.  Solid  arrows  indicate  neurons  labelled  for 
peripherin  only,  open  arrows  show  neurons  double-labelled  for  both  HO1  and 
peripherin; Scale bar: 50 m.
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Figure 4 Proportion of HO1-immunoreactive neurons related to the total number 
of submucous neurons in the duodenum, ileum and colon. A: Only in controls; B: 
In control, diabetic and insulin-treated diabetic rats.  Data are expressed as mean ± 
SE; fP < 0.0001 vs control duodenum; gP < 0.0001 vs control ileum, aP < 0.05 and eP < 
0.0001  vs controls, and  dP  < 0.01  vs diabetics.  IR:  Immunoreactive;  C:  Controls; D: 
Diabetics; ID: Insulin-treated diabetics.
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Figure 5 Representative fluorescent micrograph of a whole-mount preparation of 
submucous ganglia from the colon of a control rat after HO2-peripherin double-
labelling  immunohistochemistry.  Solid  arrows  indicate  neurons  labelled  for 
peripherin  only,  open  arrows  show  neurons  double-labelled  for  both  HO2  and 
peripherin; Scale bar: 50 m.
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Figure 6 Proportion of HO2-immunoreactive neurons related to the total number 
of submucous neurons in the duodenum, ileum and colon. A: Only in controls; B: 
In control, diabetic and insulin-treated diabetic rats. Data are expressed as mean ± 
SE;  fP  < 0.0001  vs control  duodenum,  gP  < 0.0001  vs control  ileum,  eP  < 0.001  vs 
controls, and bP < 0.05 vs diabetics; C: Controls; D: Diabetics. IR: Immunoreactive; ID: 
Insulin-treated diabetics.
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Table 1 Weight and glycaemic characteristics of the three experimental groups of 
rats
 Weight (g) Blood glucose level (mmol/L)
 Initial Final Initial Average
Controls (n = 5) 232.2 ± 7.29 486 ± 4.93a 7.08 ± 0.22 6.3 ± 0.13
Diabetics (n = 6) 235.3 ± 10.48 382.7 ± 3.53a,b 6.6 ± 0.1 23.31 ± 0.53a,b
Insulin-treated diabetics (n = 4) 251.5 ± 4.35 481.5 ± 13.4a,c 6.65 ± 0.18 9.48 ± 0.14a,b,c
Data are expressed as mean ± SE; aP < 0.0001 vs initial, bP < 0.0001 vs final controls, 
and cP < 0.0001 vs final diabetics.
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